Morey A. Blinder, MD

Morey A. Blinder, MD



  • Hematology Division
    Mail Stop 8125-0022-01, Washington University, 660 South Euclid Avenue, St. Louis, MO 63110 (mail)
  • Suite 1101 Wohl Hospital (office)

Clinical Interest: Disorders of iron metabolism; Sickle cell disease; Immune-mediated hematologic disease; Bleeding and thromboembolic disorders

Research Interest: Treatment of iron overload disorders and iron deficiency; Management of sickle cell disease; Treatment of ITP and TTP

My research focus is on the clinical treatment of patients with non-malignant hematologic disease. In particular, we have provided comprehensive care to a large cohort of adult patients with sickle cell disease as part of a funded Adult Hemoglobinopathy Treatment Center and have participated in several investigator-initiated and sponsored studies. For the treatment of sickle cell disease, one current focus is in further understanding the issues in transitioning from pediatric to adult care. Another focus is in the understanding and treatment of iron overload disorders with oral iron chelators. In addition to iron overload, I also have a longstanding interest in the diagnosis and treatment of iron deficiency anemia including the use of IV iron agents.

The second major clinical focus is the treatment of immune-mediated hematologic disease, most notably including ITP and TTP, with both newer regimens of immunosuppression as well as small molecules. We have participated in several clinical trials evaluating new approaches to the treatment of these diseases.

Lastly, my focus has been on the diagnosis and treatment of bleeding and thromboembolic disorders, including the participation in several multicenter studies for the treatment of venous thromboembolism. We have also recently established a Comprehensive Hemophilia Treatment Center including a multidisciplinary approach and are expanding our role in the hemophilia community.



  • 1981-1977: MD, St. Louis University School of Medicine, St. Louis, MO
  • 1977-1973: BS, University of Notre Dame, Notre Dame, IN

Post-Graduate Training

  • 1990-1986: Post-doctoral Research Fellow, Division of Hematology-Oncology, Washington University School of Medicine, St. Louis, MO
  • 1986-1984: Fellow in Hematology, Department of Internal Medicine, University of Washington School of Medicine, Seattle, WA
  • 1984-1981: Resident in Internal Medicine, Department of Medicine, University of Illinois School of Medicine, Chicago, IL

Academic Positions

  • 2017-present: Associate Clinical Director, Division of Hematology, Washington University School of Medicine, St. Louis, MO
  • 2013-present: Professor of Medicine and Pathology & Immunology, Washington University School of Medicine, St. Louis, MO
  • 1996-present: Associate Member, Alvin J. Siteman Cancer Center
  • 1994-present: Medical Director, Wohl Hematology Laboratory
  • 2013-1998: Associate Professor of Medicine and Pathology & Immunology, Washington University School of Medicine, St. Louis, MO
  • 1998-1990: Assistant Professor, Division of Laboratory Medicine, Washington University School of Medicine, St. Louis, MO

University & Hospital Appointments & Committees

  • 2016-present: Courtesy Assistant Professor, Goldfarb School of Nursing at Barnes-Jewish College
  • 2015-present: Hemostasis Subcommittee of the BJC/BJH Pharmacy and Therapeutics Committee
  • 2014-present: Mentors in Medicine Board of Directors, Division of Medical Education, Washington University School of Medicine
  • 2007-present: Transfusion Committee, Barnes-Jewish Hospital
  • 2000-present: Medical Staff Association, Barnes-Jewish Hospital
  • 1990-present: Barnes-Jewish Hospital Medical Staff
  • 2019-2010: Associate Director, Hematology-Oncology Fellowship Program
  • 2007-2005: Vice Chair of the Executive Committee of the Faculty Council, Washington University School of Medicine

Board Certification

  • 1988: Diplomate of the American Board in Hematology
  • 1987: Diplomate of the American Board in Medical Oncology
  • 1984: Diplomate of the American Board of Internal Medicine

Honors & Awards

  • 2008-present: Chairman, Sickle Cell Anemia Standing Committee, State of Missouri, Department of Health and Senior Services
  • 2004-present: Missouri Genetic Disease Advisory Committee, Appointed by Governor Bob Holden; Reappointed by Governor Matt Blunt 2006; Reappointed by Governor Jay Nixon 2010
  • 2020-2001: Listed in Best Doctors in America
  • 2019: Teaching Faculty of the Year, Internal Medicine Residency, Washington University
  • 2019-2001: Listed in Castle Connolly America’s Top Doctors
  • 2017: Distinguished Faculty Teaching Award, Department of Medicine House Staff
  • 1999: Dr. Neville Grant Award for Clinical Excellence
  • 1995: Outstanding Teacher for the 1994-95 Academic Year, Department of Internal Medicine, Washington University School of Medicine
  • 1989-1987: Fellow of the American Heart Association, Missouri Affiliate

Professional Societies

  • 1995: Academy of Clinical Laboratory Physicians and Scientists
  • 1993: American College of Physicians, Member
  • 1992: American Society of Hematology

Consulting Relationships & Board Memberships

  • 2020-present: Steering Committee, Agios Pharmaceuticals
  • 2011-present: Chairman, Safety Monitoring Committee, National Heart, Lung and Blood Institute (NHLBI), Safety to Reduce Iron Deficiency (STRIDE) Study
  • 2011-present: Panel Member, NCCN Guidelines – Cancer and Chemotherapy-Induced Anemia
  • 2011-2008: Data and Safety Monitoring Board, National Institute of Neurologic Disorders and Stroke Desferoxamine in Intracranial Hemorrhage Trial

Selected Publications